Jim Fulton

Partner
fultonjf@cooley.com
Full contact info

I’m a problem solver. If there’s an elegant (aka simple) solution to something, I’ll find it. If something more is needed, we will figure that out, too.

About Jim

Jim Fulton focuses on representing both emerging and established technology, healthcare and biotechnology companies and the venture capital firms that invest in those companies. Concentrating in corporate and securities law, he counsels companies throughout their lifecycle on matters ranging from company formations, private financings, employee equity incentives and executive hiring, to complex spinouts, mergers and acquisitions, IPOs and SEC reporting and compliance. In the last 10 years alone, Jim has worked on more than 350 venture capital transactions, raising more than $4 billion.

View full bio

Passions

Jim is an avid cyclist and runner and competes regularly in a variety of races and events. He is also a passionate soccer fan and travels the country and the world to see some of the top matches. But most of all, he is a devoted husband and father.

Experience

Yurts Raises $40 Million Series B

Yurts Raises $40 Million Series B

December 3, 2024

Cooley advised Yurts, an artificial intelligence integration platform that can be deployed within high-security businesses, including the US Department of Defense, on its $40 million Series B.

Read more

Related contacts

Derek Colla
Partner, Miami
Katherine King
Associate, Washington, DC
Jim Fulton
Partner, New York
Christian Plaza
Partner, Reston
Grant Schweikert
Special Counsel, Washington, DC
Tyler Kennedy
Associate
Bomin Kim
Associate, New York
James Taylor
Patent Technical Advisor, London
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

Emerging Companies
Artificial Intelligence
Technology
Technology Transactions
CFIUS

DEFCON AI Announces $44 Million Seed Financing

DEFCON AI Announces $44 Million Seed Financing

August 20, 2024

Cooley advised DEFCON AI, an insights company that’s building a next-generation modeling, simulation and analysis tool set for the modern military environment, on its $44 million in Seed financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Robert Warshaw
Associate, New York
David Fletcher
Partner, Washington, DC
Jim Fulton
Partner, New York
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Jean Park
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Ryan Montgomery
Partner, Boston
Grant Schweikert
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Ryan Guo
Associate, New York
Norris Kadet
Associate, New York
Katharina Schwarz
Associate, New York
Jill Simon
Senior Paralegal, New York
Katie Kissner
Quantitative Analyst, San Francisco
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

National Security
Artificial Intelligence
CFIUS
Emerging Companies
Tax
Technology
Technology Transactions
Cyber/Data/Privacy
Capital Markets
Compensation and Benefits

MapLight Therapeutics Closes Oversubscribed $225 Million Series C

MapLight Therapeutics Closes Oversubscribed $225 Million Series C

November 3, 2023

Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company, on its oversubscribed $225 million Series C financing.

Read more

Related contacts

Christian Plaza
Partner, Reston
Matthew Schwee
Partner, Reston
David Brinton
Associate, Washington, DC
Dr. Michael Tuscan
Partner, Washington, DC
Jim Fulton
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Dr. Jason Valentine
Associate, Washington, DC
Cortney Smith
Senior Paralegal, Reston
Jeffery Wyzykowski
Patent Agent, Washington, DC
Dou Yeon Youn
Patent Agent, New York
Zhipeng Zheng
Patent Agent, Washington, DC
Andrew Leonard
Associate, Washington, DC

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences
Healthcare
Patent Counseling and Prosecution – Life Sciences
Antitrust and Competition

Kriya Announces $270 Million Series C Financing

Kriya Announces $270 Million Series C Financing

May 20, 2022

Cooley advised Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, on its $270 Million Series C financing round. Lawyers Lauren Creel and Lindsy Solanki led the Cooley team advising Kriya.

Read more

Related contacts

Lauren Creel
Partner, Palo Alto
Lindsy Solanki
Special Counsel, Palo Alto
Kristina Krasnikova
Associate, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Jim Fulton
Partner, New York
Sarah Oliai
Associate, Washington, DC
Josh Seidenfeld
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences
Biotechnology

Chingona Ventures Closes New $52 Million Fund

Chingona Ventures Closes New $52 Million Fund

May 17, 2022

Cooley advised Chingona Ventures, a venture capital firm that invests in founders whose backgrounds uniquely position them to create businesses in growth markets that are often overlooked, on the closing of its new $52 million fund. Lawyers Rachel Goddard, Noah Pittard, Mystery Murphy, Mandy Kondo and Christine Zhao led the Cooley team advising Chingona Ventures.

Read more

Related contacts

Rachel Goddard
Partner, Chicago
Noah Pittard
Partner, Colorado
Mystery Murphy
Special Counsel, Colorado
Halima A. Nguyen
Associate, Chicago
Miriam Petrillo
Partner, Chicago
Leslie Cancel
Special Counsel, San Francisco
Jim Fulton
Partner, New York
Christopher Kimball
Partner, Washington, DC
Selin Akkan
Associate, Palo Alto
Aaron Velli
Partner, Washington, DC
Bernard Hatcher
Senior Counsel, San Francisco

Related Practices & Industries

Fund Formation
Venture Capital
Technology
View more

Admissions and credentials

California

District of Columbia

New York

Tennessee

Rankings and accolades

Best Lawyers: Corporate Law, Securities/Capital Markets Law and Venture Capital Law (2007-2021)

Best Lawyers in America: Lawyer of the Year - Securities/Capital Markets Law (2021)

Northern California Super Lawyer: Securities and Corporate Finance (2007-2012)

New York Super Lawyer (2015-2019, 2021-2022)

Legal 500 US: M&A/Corporate and Commercial - Venture Capital and Emerging Companies (2015)

Memberships and affiliations

American Bar Association (ABA)